Prostate Cancer Center

Pelvic Muscle Exercises

Pelvic muscle exercises, also known as kegels, 是改善尿失禁和防止其恶化的重要组成部分吗. Learn more.

Erectile Dysfunction

勃起功能障碍影响着数以百万计的男性，其发生的原因有很多, 但也有很多治疗方法可以让你继续拥有令人满意的性生活.

Penile Injections

Although you probably find the idea of injecting something into your penis unappealing, 许多男性对这种疗法非常满意. Learn why.

A Phase 1 Safety and Efficacy Study of IS-002 Injection in Patients Undergoing Robotic Prostatectomy Using the da Vinci® Surgical System With Firefly® Fluorescent Imaging

This is a Phase 1, single-site, interventional clinical trial evaluating the safety and efficacy of IS-002 intravenous (IV) injection for fluorescent identification and delineation of the positive cancer margins and metastatic lymph nodes during prostatectomy surgery using the da Vinci® X/Xi Surgical System with Firefly® Fluorescent Imaging.

一项随机临床试验:运动vs. 选择主动监测前列腺癌的男性的常规护理

The AS RCT study is a randomized controlled trial of 16-weeks aerobic exercise (home-based walking) vs. 主动监测前列腺癌患者的常规护理.

饮食的随机对照试验 & 前列腺癌患者的运动干预(前列腺8-II)

The Prostate 8-II study is a 2-year randomized controlled trial of testing different combinations of educational and supportive tools related to diet and exercise to evaluate biological, clinical, and quality of life outcomes in men choosing radical prostatectomy as treatment for prostate cancer.

A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of study entry.

177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

This phase Ib trial studies the dose and schedule of 177Lu-PSMA-617 and pembrolizumab in treating patients with castration-resistant prostate cancer that has spread to other places in the body.

A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

This study will test the safety and efficacy of FOR46 given every 21 days to patients with metastatic castration-resistant prostate cancer.

NRG- GU 008: Randomized Phase III Trial Incorporating Abiraterone Acetate with Prednisone and Apalutamide and Advanced Imaging into Salvage Treatment for Patients with Node-Positive Prostate Cancer After Radical Prostatectomy

这个III期试验研究了添加阿帕鲁胺的效果, abiraterone acetate, and prednisone to the usual hormone therapy and radiation therapy works compared to the usual hormone therapy and radiation therapy in treating patients with node-positive prostate cancer after surgery.